Monthly Prescribing Reference

Abbott’s SCS Systems Approved for Nonsurgical Refractory Back Pain

Credit: Shutterstock. Study participants suffered from chronic back pain for an average of 12.8 years. The Food and Drug Administration (FDA) has expanded the approval of Abbott’s spinal cord ...
Nasdaq

Abbott's (ABT) Eterna SCS System Receives FDA's Approval

Abbott Laboratories ABT recently received FDA approval for its Eterna spinal cord stimulation (SCS) system for treating chronic pain. The Eterna SCS system is the smallest implantable, rechargeable ...
Monthly Prescribing Reference

Abbott’s Next Generation SCS System Provides Broader Pain Coverage

Credit: Shutterstock. FlexBurst360 therapy provides pain coverage across up to 6 areas of the trunk and/or limbs and enables adjustable programming. The Food and Drug Administration (FDA) has approved ...
MD&M East

Abbott Snags Eterna SCS FDA Greenlight

Abbott has obtained FDA clearance of its Eterna spinal cord stimulation (SCS) system for the treatment of chronic pain. The system is the smallest implantable, rechargeable SCS — thin wires placed ...
Seeking Alpha

Abbott Receives FDA Approval for Its Spinal Cord Stimulation Systems to Treat Chronic Back Pain in People Who Have Limited Surgical Options

ABBOTT PARK, Ill., May 16, 2023 /PRNewswire/ -- Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved its spinal cord stimulation (SCS) devices for the treatment of ...
Business Insider

FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy

The new indication for Abbott's Proclaim™ XR SCS system provides a non-medication option for people with painful diabetic peripheral neuropathy Spinal cord stimulation is proven to be more effective ...
MobiHealthNews

Abbott app replacing neuromodulation system controllers receives FDA approval

Abbott has received FDA approval for a neuromodulation system-controller app that runs on iOS devices, the company announced Thursday. Compatible with Abbott's broader NeuroSphere Digital Care ...
Nasdaq

Abbott : FDA Approves Expanded MRI Compatibility For Proclaim XR SCS System With Octrode Leads

(RTTNews) - Abbott (ABT) said that the U.S. Food and Drug Administration has approved new expanded magnetic resonance imaging or MRI compatibility for its Proclaim XR Spinal Cord Stimulation (SCS) ...
Healio

FDA approves spinal cord stimulation system for chronic, nonsurgical back pain

Please provide your email address to receive an email when new articles are posted on . Abbott has announced the FDA expanded the indication of its BurstDR spinal cord stimulation devices for treating ...
Medscape

FDA OKs Expanded MRI Labeling for Eterna Spinal Cord System for Chronic Pain

The US Food and Drug Administration (FDA) has approved expanded MRI labeling for Abbott Laboratories' Eterna spinal cord stimulation (SCS) system, which will allow for higher-quality scan images for ...
Hosted on MSN

Abbott touts neuromodulation portfolio’s long-term benefits

Abbott has touted the potential of its neuromodulation portfolio in reducing patient and healthcare burdens associated with chronic pain following the positive results of three five-year analyses. The ...